1. Home
  2. TRDA vs SWBI Comparison

TRDA vs SWBI Comparison

Compare TRDA & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$10.29

Market Cap

386.8M

Sector

Health Care

ML Signal

HOLD

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$9.91

Market Cap

453.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
SWBI
Founded
2016
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
386.8M
453.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TRDA
SWBI
Price
$10.29
$9.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$20.00
$11.00
AVG Volume (30 Days)
167.3K
796.6K
Earning Date
11-06-2025
12-04-2025
Dividend Yield
N/A
5.27%
EPS Growth
N/A
N/A
EPS
N/A
0.21
Revenue
$61,520,000.00
$466,396,000.00
Revenue This Year
N/A
$2.62
Revenue Next Year
$3.14
$3.23
P/E Ratio
N/A
$47.20
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$7.73
52 Week High
$18.76
$11.50

Technical Indicators

Market Signals
Indicator
TRDA
SWBI
Relative Strength Index (RSI) 53.45 48.56
Support Level $9.89 $10.62
Resistance Level $11.55 $10.49
Average True Range (ATR) 0.51 0.21
MACD -0.21 -0.11
Stochastic Oscillator 25.90 2.67

Price Performance

Historical Comparison
TRDA
SWBI

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

Share on Social Networks: